These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10101272)

  • 61. Impaired response of VLDL lipid and apoB secretion to endotoxin in the fasted rat liver.
    Aspichueta P; Pérez-Agote B; Pérez S; Ochoa B; Fresnedo O
    J Endotoxin Res; 2006; 12(3):181-92. PubMed ID: 16719989
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis.
    Olofsson SO; Borèn J
    J Intern Med; 2005 Nov; 258(5):395-410. PubMed ID: 16238675
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The hypolipidemic effect of cilostazol can be mediated by regulation of hepatic low-density lipoprotein receptor-related protein 1 (LRP1) expression.
    Kim HJ; Moon JH; Kim HM; Yun MR; Jeon BH; Lee B; Kang ES; Lee HC; Cha BS
    Metabolism; 2014 Jan; 63(1):112-9. PubMed ID: 24139096
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhibitors of hepatic microsomal triacylglycerol hydrolase decrease very low density lipoprotein secretion.
    Gilham D; Ho S; Rasouli M; Martres P; Vance DE; Lehner R
    FASEB J; 2003 Sep; 17(12):1685-7. PubMed ID: 12958176
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Perfluorooctanoic acid binds to peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation in 3T3-L1 adipocytes.
    Yamamoto J; Yamane T; Oishi Y; Kobayashi-Hattori K
    Biosci Biotechnol Biochem; 2015; 79(4):636-9. PubMed ID: 25516096
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly.
    Tsai J; Qiu W; Kohen-Avramoglu R; Adeli K
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):211-8. PubMed ID: 17038630
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice.
    Cano A; Buqué X; Martínez-Uña M; Aurrekoetxea I; Menor A; García-Rodríguez JL; Lu SC; Martínez-Chantar ML; Mato JM; Ochoa B; Aspichueta P
    Hepatology; 2011 Dec; 54(6):1975-86. PubMed ID: 21837751
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nascent VLDL phospholipid composition is altered when phosphatidylcholine biosynthesis is inhibited: evidence for a novel mechanism that regulates VLDL secretion.
    Fast DG; Vance DE
    Biochim Biophys Acta; 1995 Sep; 1258(2):159-68. PubMed ID: 7548179
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Endoplasmic reticulum-localized hepatic lipase decreases triacylglycerol storage and VLDL secretion.
    Erickson B; Selvan SP; Ko KW; Kelly K; Quiroga AD; Li L; Nelson R; King-Jones K; Jacobs RL; Lehner R
    Biochim Biophys Acta; 2013 Jun; 1831(6):1113-23. PubMed ID: 23376223
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vitro reconstitution of assembly of apolipoprotein B48-containing lipoproteins.
    Rusiñol AE; Jamil H; Vance JE
    J Biol Chem; 1997 Mar; 272(12):8019-25. PubMed ID: 9065474
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster.
    Carpentier A; Taghibiglou C; Leung N; Szeto L; Van Iderstine SC; Uffelman KD; Buckingham R; Adeli K; Lewis GF
    J Biol Chem; 2002 Aug; 277(32):28795-802. PubMed ID: 12048212
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hypothesis II: The majority of VLDL-apoB48 remnants in postprandial plasma are derived from the liver, not from the intestine.
    Nakajima K; Tokita Y; Tanaka A
    Clin Chim Acta; 2019 Mar; 490():12-16. PubMed ID: 30553860
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Retention of orotic acid effect on very low density lipoproteins secretion in cultured hepatocytes.
    Hebbachi AM; Gibbons GF
    Biochem Soc Trans; 1996 May; 24(2):177S. PubMed ID: 8736835
    [No Abstract]   [Full Text] [Related]  

  • 74. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
    Venkatesan N; Devaraj SN; Devaraj H
    Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Alterations by perfluorooctanoic acid of glycerolipid metabolism in rat liver.
    Kudo N; Mizuguchi H; Yamamoto A; Kawashima Y
    Chem Biol Interact; 1999 Mar; 118(1):69-83. PubMed ID: 10227579
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bile acids suppress the secretion of very-low-density lipoprotein by human hepatocytes in primary culture.
    Lin Y; Havinga R; Verkade HJ; Moshage H; Slooff MJ; Vonk RJ; Kuipers F
    Hepatology; 1996 Feb; 23(2):218-28. PubMed ID: 8591844
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Effects of perfluorooctanoic acid on oxidative stress and PPARα and its related CYP4A1 gene expression in rat liver].
    Wang L; Zhao F; Kan M; Wen Z; Zhou Y; Yu L; Liu H
    Wei Sheng Yan Jiu; 2017 Sep; 46(5):802-806. PubMed ID: 29903312
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers.
    Olsen GW; Burris JM; Burlew MM; Mandel JH
    Drug Chem Toxicol; 2000 Nov; 23(4):603-20. PubMed ID: 11071397
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Insulin suppression of VLDL apo B secretion is not mediated by the LDL receptor.
    Chirieac DV; Cianci J; Collins HL; Sparks JD; Sparks CE
    Biochem Biophys Res Commun; 2002 Sep; 297(1):134-7. PubMed ID: 12220520
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bezafibrate and clofibric acid are novel inhibitors of phosphatidylcholine synthesis via the methylation of phosphatidylethanolamine.
    Nishimaki-Mogami T; Suzuki K; Okochi E; Takahashi A
    Biochim Biophys Acta; 1996 Nov; 1304(1):11-20. PubMed ID: 8944746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.